SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending as the Trump administration is reportedly in talks to take equity stakes in quantum computing firms, potentially providing a boost to the sector. The community is actively discussing the implications of this government involvement and whether it will trigger a short squeeze. Amidst this news, there are debates regarding the company's valuation and future prospects within the quantum computing landscape.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending amid discussions of potential government investment in quantum computing firms, sparking debates about the sector's speculative nature and long-term potential.  Community members are weighing the significance of this backing, while some express skepticism about the technology's current valuation and practical applications. The news is driving volatility, with both bulls and bears actively strategizing around potential price movements.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid discussions about a potential equity stake from the Trump administration in exchange for federal funding, as reported by the WSJ. Community chatter revolves around the potential impact of this news, with some anticipating a short squeeze while others express skepticism about the amount of funding. There is debate about how this government involvement will impact the quantum computing sector, which also includes names such as IONQ and RGTI.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending as discussion centers around the potential impact of government investment in quantum computing firms and the company's positioning with its 'Made in USA' post-quantum chips. Community members are actively debating the possibility of a short squeeze, comparing it to past events with other quantum stocks, while also pointing to potential government contracts on the horizon. Talk also focuses on the impact of the latest stock offering on price action.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla ($TSLA) is trending as investors digest its latest earnings report, with key talking points revolving around AI advancements and the future of robotaxis. The community is actively debating the company's profitability, growth prospects, and Elon Musk's vision amid discussions of potential market overvaluation. Sentiment appears mixed, with some expressing concerns about margins and future performance, while others remain optimistic about Tesla's long-term potential in AI and robotics.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as the community discusses its potential in the quantum computing space, particularly its ties to Infleqtion and government backing. Recent news about Infleqtion's involvement in upcoming AI and quantum conferences, as well as potential partnerships, are fueling interest. Some investors believe $CCCX is undervalued compared to its peers in the sector, while others are wary of market volatility and potential risks associated with SPAC mergers.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is trending amid community discussion around large, out-of-the-money call option buying, specifically the Nov 21 $385 strike, which some speculate could be tied to potential acquisition news or regulatory changes. Some traders are pointing to the upcoming lockup period expiration and earnings as potential catalysts, while others highlight Wells Fargo's updated overweight rating with a $160 price target as a positive signal.

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Armata Pharmaceuticals Inc

Armata Pharmaceuticals ($ARMP) is trending after promising Phase 2a trial results for its phage therapy targeting Staph aureus bacteremia, with community members highlighting the potential for a new standard of care and the stock's volatile price action. Bullish sentiment focuses on the news catalyst, small float, and backing from Innoviva and the U.S. government, while bears cite potential dilution and historical volatility.

Houston American Energy Corp. is an independent oil and gas company, which engages in the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. The firm holds interest in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region and in the South American country of Colombia. It operates through the North America and South America geographical segments. The company was founded on April 2, 2001 and is headquartered in Houston, TX.

Houston American Energy Corp

HUSA is trending due to discussions around its potential in the oil sector amid geopolitical tensions and sanctions, with community members weighing its low float and possible breakouts. Some traders are actively debating the company's fundamentals and potential for a short squeeze, while others discuss specific price levels as possible entry or exit points. Recent news and technical analysis are fueling the discussions, although opinions on the stock's future direction remain divided.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending, with community members actively promoting its Telegram and X communities. The coin is being touted as an alternative to Bitcoin, but "way higher", with focus on community, culture, and steady growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease

Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile.
read more...

Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health

Andrew Berens, an analyst from Leerink Partners, maintained the Buy rating on Aura Biosciences Inc (AURA Research Report). The associated price t...

Aura Biosciences (AURA, $7.7) Aroon Indicator entered a Downtrend on March 27, 2024.

For the last three days, A.I.dvisor has detected that AURA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Recap: Aura Biosciences Q4 Earnings

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer...

Contrasting Aura Biosciences (NASDAQ:AURA) and Atara Biotherapeutics (NASDAQ:ATRA)

Aura Biosciences (NASDAQ:AURA  Get Free Report) and Atara Biotherapeutics (NASDAQ:ATRA  Get Free Report) are both small-cap medical companies, but which is the better investment? We...

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced...

Aura Biosciences (AURA, $8) Aroon Indicator entered a Downtrend on February 13, 2024.

Commit To Purchase Aura Biosciences At $7.50, Earn 32.6% Annualized Using Options

Investors considering a purchase of Aura Biosciences Inc (AURA) shares, but cautious about paying the going market price of 8.25/share, might benefit from considering selling puts among the...

Aura Biosciences (AURA, $8.9) Aroon Indicator entered a Downtrend on February 12, 2024.

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

AURA
Aura Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AURA News

AURAAura Biosciences Inc